International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) 2017

Short resume:

function
90%
cognitive
80%
hopkins
80%
life
80%

Finally, a Big Win for a Monoclonal in Alzheimer’s Monoclonal antibodies may yet be an answer for treating Alzheimer’s disease, results of an early but very encouraging study have shown.
Source Medscape
Read More…

Other News

Be the first to comment

Leave a Reply

Your email address will not be published.


*